Treatment of relapsed chronic lymphocytic leukemia: old and new therapies

Seminars in Oncology
John ByrdMichael R Grever

Abstract

There are several initial therapies available for chronic lymphocytic leukemia (CLL) that offer extended disease-free or treatment-free survival time. However, once patients relapse, particularly after fludarabine-based therapy, treatment choices have remained limited. Newer therapies have now become available, including alemtuzumab, fludarabine-based combinations, rituximab, methylprednisolone, alternative nucleoside analogs, flavopirodol, lenalidomide, signal transduction inhibitors/small molecules, and new monoclonal antibodies. We discuss selection of therapy for the relapsed patient using risk stratification and the role of clinical research in continuing to pursue therapeutic advances against CLL.

References

Nov 18, 1992·Journal of the National Cancer Institute·G KaurE Sausville
Nov 1, 1990·Journal of the American Academy of Dermatology·S ArmusE Bisaccia
Mar 17, 1995·The Journal of Biological Chemistry·A TreumannM A Ferguson
Dec 10, 1997·American Journal of Clinical Oncology·L B SaltzD P Kelsen
Mar 4, 2000·Journal of the National Cancer Institute·A M Senderowicz, E A Sausville
Jul 25, 2000·The Journal of Biological Chemistry·S H ChaoD H Price
Nov 21, 2000·Current Opinion in Oncology·J M Flynn, J C Byrd
Dec 15, 2000·The New England Journal of Medicine·K R RaiC A Schiffer
Jun 30, 2001·The Journal of Biological Chemistry·S H Chao, D H Price
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary K SchwartzDavid Kelsen
Jun 11, 2002·Biochemical and Biophysical Research Communications·Walter Filgueira de AzevedoNelson José Freitas da Silveira
Jul 12, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·Andres VirchisAtul Mehta
Aug 9, 2002·The New England Journal of Medicine·Stephan Stilgenbauer, Hartmut Döhner
Sep 28, 2002·Blood·Irene M PedersenJohn C Reed
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoinette R TanAdrian M Senderowicz
Nov 27, 2002·Cancer Chemotherapy and Pharmacology·James P ThomasGeorge Wilding
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FreyerV Trillet-Lenoir
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop M KantarjianMichael Keating
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A WeissDenise Horgan
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AkliluE E Vokes
Oct 11, 2003·Annals of Hematology·Patrick D ThorntonDaniel Catovsky
Jan 9, 2004·Leukemia·R AloyzL Panasci
Jan 28, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Patrick D ThorntonDaniel Catovsky

❮ Previous
Next ❯

Citations

Oct 20, 2006·Cancer Immunology, Immunotherapy : CII·Amal MansourElizabeth Raveche
Jul 31, 2008·Journal of the National Cancer Institute·Christine HerbstUNKNOWN Cochrane Haematological Malignancies Group
May 10, 2002·Clinical Journal of Oncology Nursing·Karen Seeley, Elaine DeMeyer
Mar 16, 2013·OncoTargets and Therapy·Osmond J D'Cruz, Fatih M Uckun
Apr 19, 2011·Clinical Medicine Insights. Oncology·Chadi Nabhan, Neil E Kay
Feb 21, 2007·Expert Opinion on Biological Therapy·Yiwen Li, Zhenping Zhu
Sep 5, 2007·Molecular Immunology·Martin J GlennieRonald P Taylor
Oct 26, 2006·British Journal of Haematology·Fatih M UckunSanjive Qazi
Feb 3, 2009·British Journal of Haematology·John G Gribben, Michael Hallek
Feb 27, 2008·International Reviews of Immunology·Fatih M Uckun
Apr 27, 2018·British Journal of Haematology·Cindy VargaPaul G Richardson

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.